How does aurobindo ensure worker safety with clonazepam?

How does Aurobindo monitor worker exposure to clonazepam?

Aurobindo operates dedicated containment suites for potent benzodiazepines like clonazepam. These areas use negative-pressure isolators, local exhaust ventilation, and closed-transfer systems that keep airborne dust below 0.1 µg/m³. Workers wear powered air-purifying respirators and full-body Tyvek suits during any task that could generate particles.

What training and medical surveillance programs are in place?

All staff complete annual training on benzodiazepine hazards, proper donning of personal protective equipment, and spill response. Occupational health teams conduct baseline and periodic blood tests for liver function and complete blood counts, plus urine screens for drug metabolites. Results are reviewed quarterly to detect any early signs of exposure.

How are engineering controls and equipment validated?

Before each production campaign, Aurobindo performs surface-wipe sampling and air monitoring inside the isolators. Equipment is certified to ISO 14644 cleanroom standards and undergoes smoke studies to confirm unidirectional airflow. Any deviation triggers immediate shutdown and requalification.

What happens in case of accidental exposure or spill?

Spill kits containing absorbent pads and neutralizing agents are stationed at every workstation. Workers follow a documented decontamination sequence: remove contaminated PPE, wash exposed skin with soap and water, and report to the on-site clinic for evaluation. Incidents are logged in an electronic system and investigated within 24 hours.

How does Aurobindo compare its practices with industry peers?

The company publishes an annual EHS report that benchmarks its clonazepam containment performance against FDA and EU GMP expectations. Independent third-party audits, conducted twice yearly, verify that exposure levels remain well below the 1 µg/m³ occupational exposure limit used by most major generic manufacturers.